CHESS Health
Evidence-based mobile application designed and proven to provide ongoing support and relapse prevention to people recovering from substance-use-disorders.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | $5.4m | Early VC | |
| Total Funding | 000k | ||
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 76 % | 30 % | 43 % | 66 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
CHESS Health is a pioneering company in the addiction management sector, offering an evidence-based platform designed to automate the addiction management life cycle. The company focuses on getting patients into treatment sooner, improving outcomes through digital therapy, reducing relapse rates, and supporting long-term recovery. CHESS Health serves healthcare providers, treatment centers, and government agencies, operating primarily in the healthcare and addiction recovery markets. The business model revolves around a subscription-based service, where clients pay for access to the platform and its suite of tools. Revenue is generated through these subscriptions as well as potential partnerships and grants. The platform integrates pioneering addiction therapy recovery technologies like CBT4CBT and ACHESS, which have been validated through numerous clinical trials and published studies.
Keywords: addiction management, digital therapy, relapse prevention, long-term recovery, healthcare providers, treatment centers, evidence-based, subscription model, clinical trials, recovery technologies.